360 related articles for article (PubMed ID: 37788525)
1. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
[TBL] [Abstract][Full Text] [Related]
2. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
3. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
6. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
Kraniotou C; Karadima V; Bellos G; Tsangaris GT
J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
[TBL] [Abstract][Full Text] [Related]
7. The future is now? Clinical and translational aspects of "Omics" technologies.
D'Adamo GL; Widdop JT; Giles EM
Immunol Cell Biol; 2021 Feb; 99(2):168-176. PubMed ID: 32924178
[TBL] [Abstract][Full Text] [Related]
8. Omics sciences and precision medicine in Urothelial Carcinoma.
Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
[TBL] [Abstract][Full Text] [Related]
9. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
11. Utilising the precision nutrition toolkit in the path towards precision medicine.
Sawicki C; Haslam D; Bhupathiraju S
Proc Nutr Soc; 2023 Sep; 82(3):359-369. PubMed ID: 37475596
[TBL] [Abstract][Full Text] [Related]
12. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
[TBL] [Abstract][Full Text] [Related]
14. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
15. Omics sciences and precision medicine in sarcoma.
Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
[TBL] [Abstract][Full Text] [Related]
16. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
18. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
19. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
